Članki z zahtevami za javni dostop - Irena LoryanVeč o tem
Na voljo nekje: 21
Influence of sex on propofol metabolism, a pilot study: implications for propofol anesthesia
I Loryan, M Lindqvist, I Johansson, M Hiratsuka, I Van Der Heiden, ...
European journal of clinical pharmacology 68, 397-406, 2012
Zahteve: Swedish Research Council
Sex difference in formation of propofol metabolites: a replication study
E Choong, I Loryan, M Lindqvist, Å Nordling, S El Bouazzaoui, ...
Basic & clinical pharmacology & toxicology 113 (2), 126-131, 2013
Zahteve: Swiss National Science Foundation, Swedish Research Council
UGT1A4*3 Encodes Significantly Increased Glucuronidation of Olanzapine in Patients on Maintenance Treatment and in Recombinant Systems
T Haslemo, I Loryan, N Ueda, B Mannheimer, L Bertilsson, ...
Clinical Pharmacology & Therapeutics 92 (2), 221-227, 2012
Zahteve: Swedish Research Council
Effect of transporter inhibition on the distribution of cefadroxil in rat brain
X Chen, I Loryan, M Payan, RF Keep, DE Smith, M Hammarlund-Udenaes
Fluids and Barriers of the CNS 11, 1-12, 2014
Zahteve: US National Institutes of Health
Neuropharmacokinetic visualization of regional and subregional unbound antipsychotic drug transport across the blood–brain barrier
D Luptáková, T Vallianatou, A Nilsson, R Shariatgorji, ...
Molecular psychiatry 26 (12), 7732-7745, 2021
Zahteve: Swedish Research Council, European Commission
Mechanistic Study on the Use of the l-Type Amino Acid Transporter 1 for Brain Intracellular Delivery of Ketoprofen via Prodrug: A Novel Approach Supporting the …
E Puris, M Gynther, ECM de Lange, S Auriola, M Hammarlund-Udenaes, ...
Molecular Pharmaceutics 16 (7), 3261-3274, 2019
Zahteve: Academy of Finland
Amorphisation of free acid ibuprofen and other profens in mixtures with nanocellulose: dry powder formulation strategy for enhanced solubility
A Mantas, V Labbe, I Loryan, A Mihranyan
Pharmaceutics 11 (2), 68, 2019
Zahteve: Knut and Alice Wallenberg Foundation
Molecular basis of mood and cognitive adverse events elucidated via a combination of pharmacovigilance data mining and functional enrichment analysis
C Andronis, JP Silva, E Lekka, V Virvilis, H Carmo, K Bampali, M Ernst, ...
Archives of toxicology 94 (8), 2829-2845, 2020
Zahteve: European Commission
Differential blood–brain barrier transport and cell uptake of cyclic peptides in vivo and in vitro
E Melander, C Eriksson, S Wellens, K Hosseini, R Fredriksson, F Gosselet, ...
Pharmaceutics 15 (5), 1507, 2023
Zahteve: Swedish Research Council, European Commission
Analysis of the contributing role of drug transport across biological barriers in the development and treatment of chemotherapy-induced peripheral neuropathy
Y Hu, M Girdenyté, L Roest, I Liukkonen, M Siskou, F Bällgren, ...
Fluids and Barriers of the CNS 21 (1), 13, 2024
Zahteve: European Commission
Neurofilament light chain in plasma as a sensitive diagnostic biomarker of peripheral neurotoxicity: In Vivo mouse studies with oxaliplatin and paclitaxel-NeuroDeRisk project
D Balayssac, J Busserolles, C Broto, C Dalbos, L Prival, S Lamoine, ...
Biomedicine & Pharmacotherapy 167, 115535, 2023
Zahteve: European Commission
Active uptake of oxycodone at both the blood-cerebrospinal fluid barrier and the blood-brain barrier without sex differences: a rat microdialysis study
F Bällgren, M Hammarlund-Udenaes, I Loryan
Pharmaceutical research 40 (11), 2715-2730, 2023
Zahteve: Swedish Research Council
The solute carrier SLC7A1 may act as a protein transporter at the blood-brain barrier
M Kurtyka, F Wessely, S Bau, E Ifie, L He, NM de Wit, ABV Pedersen, ...
European journal of cell biology 103 (2), 151406, 2024
Zahteve: Wellcome Trust, European Commission
Reduced oxycodone brain delivery in rats due to lipopolysaccharide-induced inflammation: microdialysis insights into brain disposition and sex-specific pharmacokinetics
F Bällgren, M Hammarlund-Udenaes, I Loryan
Fluids and Barriers of the CNS 21 (1), 1-18, 2024
Zahteve: European Commission
Active CNS delivery of oxycodone in healthy and endotoxemic pigs
F Bällgren, T Bergfast, A Ginosyan, J Mahajan, M Lipcsey, ...
Fluids and Barriers of the CNS 21 (1), 86, 2024
Zahteve: European Commission
Ceftazidime-avibactam (CAZ-AVI) pharmacokinetics in critically ill patients undergoing continuous venovenous hemodiafiltration (CVVHDF)
A O'Jeanson, K Ioannidis, EI Nielsen, L Galani, A Ginosyan, H Paskalis, ...
International Journal of Antimicrobial Agents 65 (1), 107394, 2025
Zahteve: European Commission
The challenge to identify sensitive safety biomarkers of peripheral neurotoxicity in the rat: A collaborative effort across industry and academia (IMI NeuroDeRisk project)
L Micheli, D Balayssac, J Busserolles, C Dalbos, L Prival, D Richard, ...
Toxicology 510, 153998, 2025
Zahteve: European Commission
Formulation-dependent differences in paclitaxel distribution to anatomical sites relevant to chemotherapy-induced peripheral neuropathy
M Girdenytė, Y Hu, A Ginosyan, M Hammarlund-Udenaes, I Loryan
Frontiers in Pharmacology 15, 1486686, 2024
Zahteve: European Commission
Regional distribution of unbound eletriptan and sumatriptan in the CNS and PNS in rats: implications for a potential central action
N Svane, F Bällgren, A Ginosyan, M Kristensen, B Brodin, I Loryan
The Journal of Headache and Pain 25 (1), 187, 2024
Zahteve: European Commission
Region-independent active CNS net uptake of marketed H+/OC antiporter system substrates
F Bällgren, Y Hu, S Li, L Van De Beek, M Hammarlund-Udenaes, I Loryan
Frontiers in Cellular Neuroscience 18, 1493644, 2024
Zahteve: European Commission
Podatke o objavi in financiranju samodejno določi računalniški program